These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14989427)

  • 21. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy.
    Cohen SB; Strand V; Aguilar D; Ofman JJ
    Rheumatology (Oxford); 2004 Jun; 43(6):704-11. PubMed ID: 14997006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B
    BioDrugs; 2001; 15(2):87-97. PubMed ID: 11437678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anakinra: new preparation. Weakly effective in rheumatoid arthritis.
    Prescrire Int; 2004 Apr; 13(70):43-5. PubMed ID: 15148945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis].
    Riente L
    Reumatismo; 2004; 56(1 Suppl 1):74-9. PubMed ID: 15201943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anakinra shows promise for treating patients with rheumatoid arthritis.
    McIntosh T; Freeman TR
    J Am Pharm Assoc (Wash); 2002; 42(4):660-2. PubMed ID: 12150367
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.
    Bresnihan B; Newmark R; Robbins S; Genant HK
    J Rheumatol; 2004 Jun; 31(6):1103-11. PubMed ID: 15170922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of rheumatoid arthritis by interleukin-1 receptor antagonist].
    Wendling D; Jorgensen C
    Rev Med Interne; 2002 Dec; 23(12):1006-11. PubMed ID: 12504237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anakinra for rheumatoid arthritis.
    Mertens M; Singh JA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005121. PubMed ID: 19160248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade.
    Buch MH; Bingham SJ; Seto Y; McGonagle D; Bejarano V; White J; Emery P
    Arthritis Rheum; 2004 Mar; 50(3):725-8. PubMed ID: 15022311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial.
    Le Loët X; Nordström D; Rodriguez M; Rubbert A; Sarzi-Puttini P; Wouters JM; Woolley JM; Wright N; Lawrence C; Appleton B
    J Rheumatol; 2008 Aug; 35(8):1538-44. PubMed ID: 18634163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
    Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G
    Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T; Sumida T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.
    Fleishmann RM
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S35-41. PubMed ID: 14989428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.
    Fleischmann R; Stern R; Iqbal I
    Expert Opin Biol Ther; 2004 Aug; 4(8):1333-44. PubMed ID: 15268666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist].
    Suzuki T
    Nihon Rinsho; 2002 Dec; 60(12):2397-400. PubMed ID: 12510368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
    Østergaard M; Duer A; Nielsen H; Johansen JS; Narvestad E; Ejbjerg BJ; Baslund B; Møller JM; Thomsen HS; Petersen J
    Ann Rheum Dis; 2005 Oct; 64(10):1503-6. PubMed ID: 15778238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
    Kalliolias GD; Liossis SN
    Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anakinra for rheumatoid arthritis: a systematic review.
    Mertens M; Singh JA
    J Rheumatol; 2009 Jun; 36(6):1118-25. PubMed ID: 19447938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.